Literature DB >> 33671744

Cigarette Smoking, miR-27b Downregulation, and Peripheral Artery Disease: Insights into the Mechanisms of Smoking Toxicity.

Tiago Pereira-da-Silva1,2, Patrícia Napoleão3, Marina C Costa3,4, André F Gabriel3,4, Mafalda Selas1, Filipa Silva1, Francisco J Enguita3,4, Rui Cruz Ferreira1, Miguel Mota Carmo5.   

Abstract

Cigarette smoking is a risk factor for the development of peripheral artery disease (PAD), although the proatherosclerotic mediators of cigarette smoking are not entirely known. We explored whether circulating microRNAs (miRNAs) are dysregulated in cigarette smokers and associated with the presence of PAD. Ninety-four participants were recruited, including 58 individuals without and 36 with PAD, 51 never smokers, 28 prior smokers, and 15 active smokers. The relative expression of six circulating miRNAs with distinct biological roles (miR-21, miR-27b, miR-29a, miR-126, miR-146, and miR-218) was assessed. Cigarette smoking was associated with the presence of PAD in multivariate analysis. Active smokers, but not prior smokers, presented miR-27b downregulation and higher leukocyte, neutrophil, and lymphocyte counts; miR-27b expression levels were independently associated with active smoking. Considering the metabolic and/or inflammatory abnormalities induced by cigarette smoking, miR-27b was independently associated with the presence of PAD and downregulated in patients with more extensive PAD. In conclusion, the atheroprotective miR-27b was downregulated in active smokers, but not in prior smokers, and miR-27b expression was independently associated with the presence of PAD. These unreported data suggest that the proatherogenic properties of cigarette smoking are mediated by a downregulation of miR-27b, which may be attenuated by smoking cessation.

Entities:  

Keywords:  atherosclerosis; cigarette smoking; miR-27b; peripheral artery disease

Year:  2021        PMID: 33671744     DOI: 10.3390/jcm10040890

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  6 in total

1.  Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study.

Authors:  Maria D Pinazo-Durán; Jose J García-Medina; Silvia M Sanz-González; Jose E O'Connor; Ricardo P Casaroli-Marano; Mar Valero-Velló; Maribel López-Gálvez; Cristina Peris-Martínez; Vicente Zanón-Moreno; Manuel Diaz-Llopis
Journal:  Diagnostics (Basel)       Date:  2021-04-19

2.  Special Issue "The Prevention and Treatment of Atherosclerosis".

Authors:  Anna Kabłak-Ziembicka
Journal:  J Clin Med       Date:  2022-02-16       Impact factor: 4.241

3.  MicroRNA-134-5p and the Extent of Arterial Occlusive Disease Are Associated with Risk of Future Adverse Cardiac and Cerebral Events in Diabetic Patients Undergoing Carotid Artery Stenting for Symptomatic Carotid Artery Disease.

Authors:  Rafał Badacz; Tadeusz Przewłocki; Piotr Pieniążek; Agnieszka Rosławiecka; Paweł Kleczyński; Jacek Legutko; Krzysztof Żmudka; Anna Kabłak-Ziembicka
Journal:  Molecules       Date:  2022-04-12       Impact factor: 4.927

4.  MIR600HG sponges miR-125a-5p to regulate glycometabolism and cisplatin resistance of oral squamous cell carcinoma cells via mediating RNF44.

Authors:  Xingguang Liu; Tengda Zhao; Zhe Yuan; Shaohua Ge
Journal:  Cell Death Discov       Date:  2022-04-20

5.  The Plasma Oxylipidome Links Smoking Status to Peripheral Artery Disease.

Authors:  Stephanie P B Caligiuri; Grant N Pierce; Amir Ravandi; Harold M Aukema
Journal:  Metabolites       Date:  2022-07-07

Review 6.  Inflammatory and Prothrombotic Biomarkers, DNA Polymorphisms, MicroRNAs and Personalized Medicine for Patients with Peripheral Arterial Disease.

Authors:  Pavel Poredoš; Mišo Šabovič; Mojca Božič Mijovski; Jovana Nikolajević; Pier Luigi Antignani; Kosmas I Paraskevas; Dimitri P Mikhailidis; Aleš Blinc
Journal:  Int J Mol Sci       Date:  2022-10-10       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.